Thaian N. Ton

Array ( [id] => 9306124 [patent_doc_number] => 20140044798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'Elimination of N-Glycolylneuraminic Acid From Animal Products For Human Use' [patent_app_type] => utility [patent_app_number] => 13/965880 [patent_app_country] => US [patent_app_date] => 2013-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17650 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13965880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10608309 [patent_doc_number] => 09328332 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-03 [patent_title] => 'Methods for the production of IPS cells using non-viral approach' [patent_app_type] => utility [patent_app_number] => 13/961858 [patent_app_country] => US [patent_app_date] => 2013-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21365 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 213 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13961858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9148364 [patent_doc_number] => 20130302887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-14 [patent_title] => 'COMPOSITIONS AND METHODS FOR GROWING HUMAN EMBRYONIC CELLS' [patent_app_type] => utility [patent_app_number] => 13/947884 [patent_app_country] => US [patent_app_date] => 2013-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10020 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13947884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10511219 [patent_doc_number] => 09238794 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-19 [patent_title] => 'Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells' [patent_app_type] => utility [patent_app_number] => 13/946032 [patent_app_country] => US [patent_app_date] => 2013-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 6912 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13946032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10122715 [patent_doc_number] => 09157067 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-13 [patent_title] => 'Pluripotent cells from mammalian late epiblast layer' [patent_app_type] => utility [patent_app_number] => 13/941761 [patent_app_country] => US [patent_app_date] => 2013-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7631 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13941761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11828963 [patent_doc_number] => 09725698 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-08 [patent_title] => 'Trophoblast-derived mesenchymal stem cells (T-MSCs) produced from human embryonic stem cells, methods and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/413297 [patent_app_country] => US [patent_app_date] => 2013-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 37182 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14413297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11873792 [patent_doc_number] => 09745551 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-29 [patent_title] => 'Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/413290 [patent_app_country] => US [patent_app_date] => 2013-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 36825 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 278 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14413290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9082530 [patent_doc_number] => 20130268060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-10 [patent_title] => 'METHOD FOR DIFFERENTIATING EMBRYONIC STEM CELLS INTO CELLS EXPRESSING AQP-1' [patent_app_type] => utility [patent_app_number] => 13/917269 [patent_app_country] => US [patent_app_date] => 2013-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10391 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13917269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10274135 [patent_doc_number] => 20150159133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-11 [patent_title] => 'METHOD OF IN VITRO DIFFERENTIATION OF MOTOR NEURON PROGENITORS (MNPS) FROM HUMAN INDUCED PLURIPOTENT STEM CELLS AND CRYOPRESERVATION OF MNPS' [patent_app_type] => utility [patent_app_number] => 14/406665 [patent_app_country] => US [patent_app_date] => 2013-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6648 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14406665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10221969 [patent_doc_number] => 20150106962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-16 [patent_title] => 'MINIATURE SWINE TRANSGENIC FOR ONE OR MORE COAGULATION FACTORS' [patent_app_type] => utility [patent_app_number] => 14/403764 [patent_app_country] => US [patent_app_date] => 2013-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9786 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14403764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12106460 [patent_doc_number] => 09862930 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-09 [patent_title] => 'Generation of human iPS cells by a synthetic self-replicative RNA' [patent_app_type] => utility [patent_app_number] => 14/402924 [patent_app_country] => US [patent_app_date] => 2013-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 17 [patent_no_of_words] => 22292 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14402924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10594704 [patent_doc_number] => 09315779 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-19 [patent_title] => 'Reprogramming cells' [patent_app_type] => utility [patent_app_number] => 13/896259 [patent_app_country] => US [patent_app_date] => 2013-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 22853 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13896259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9147772 [patent_doc_number] => 20130302295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-14 [patent_title] => 'FEEDER-FREE DERIVATION OF HUMAN-INDUCED PLURIPOTENT STEM CELLS WITH SYNTHETIC MESSENGER RNA' [patent_app_type] => utility [patent_app_number] => 13/893166 [patent_app_country] => US [patent_app_date] => 2013-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9613 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13893166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9582027 [patent_doc_number] => 08772031 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-08 [patent_title] => 'Composition for reprogramming somatic cells to generate induced pluripotent stem cells, comprising Oct4 in combination with Bmi1 or its upstream regulator, and method for generating induced pluripotent stem cells using the same' [patent_app_type] => utility [patent_app_number] => 13/890896 [patent_app_country] => US [patent_app_date] => 2013-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 74 [patent_no_of_words] => 11559 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13890896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9191506 [patent_doc_number] => 20130330821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'NEURAL PROGENITOR CELLS DERIVED FROM EMBRYONIC STEM CELLS' [patent_app_type] => utility [patent_app_number] => 13/874507 [patent_app_country] => US [patent_app_date] => 2013-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 27743 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13874507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9174377 [patent_doc_number] => 20130316362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'GENOTOXIC TESTING' [patent_app_type] => utility [patent_app_number] => 13/860061 [patent_app_country] => US [patent_app_date] => 2013-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11732 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13860061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14821343 [patent_doc_number] => 10407665 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-09-10 [patent_title] => Methods for generation of pluripotent and multipotent cells [patent_app_type] => utility [patent_app_number] => 14/390134 [patent_app_country] => US [patent_app_date] => 2013-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 113 [patent_no_of_words] => 32963 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14390134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9995445 [patent_doc_number] => 09040038 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-26 [patent_title] => 'Modalities for the treatment of degenerative diseases of the retina' [patent_app_type] => utility [patent_app_number] => 13/858534 [patent_app_country] => US [patent_app_date] => 2013-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10541 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13858534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10001653 [patent_doc_number] => 09045732 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-02 [patent_title] => 'Modalities for the treatment of degenerative diseases of the retina' [patent_app_type] => utility [patent_app_number] => 13/858497 [patent_app_country] => US [patent_app_date] => 2013-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10545 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13858497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8939473 [patent_doc_number] => 20130189270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-25 [patent_title] => 'METHOD FOR THE PRODUCTION OF ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/798280 [patent_app_country] => US [patent_app_date] => 2013-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7691 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13798280 [rel_patent_id] =>[rel_patent_doc_number] =>)